KMA warns that it will act decisively on Zuellig's monopolistic activity

Considerable focus is being given to the proclamation of the Korea Medical Association (hereinafter refer to as KMA) that they would take all possible measures against Zuellig and Handok Pharmaceutical Corporation.

The Emergency Committee of the KMA announced in a statement titled 'For the establishment of distribution order in medical supplies' released on the 4th that the mean scheme of ...